CSS
CVS icon

Cubist Systematic Strategies’s CVS Health CVS Stock Holding History

Cubist Systematic Strategies’s Portfolio CVS Stock Details CVS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$22.4M Buy
297,200
+3,200
+1% +$219K 0.11% 243
2025
Q2 		$20.3M Sell
294,000
-71,600
-20% -$4.7M 0.09% 292
2025
Q1 		$24.8M Sell
365,600
-34,600
-9% -$2.07M 0.15% 142
2024
Q4 		$18M Buy
400,200
+217,800
+119% +$12.2M 0.11% 239
2024
Q3 		$11.5M Sell
182,400
-9,300
-5% -$543K 0.07% 403
2024
Q2 		$11.3M Sell
191,700
-29,000
-13% -$1.81M 0.08% 348
2024
Q1 		$17.6M Buy
220,700
+101,300
+85% +$7.74M 0.1% 231
2023
Q4 		$9.43M Sell
119,400
-43,500
-27% -$3.1M 0.06% 487
2023
Q3 		$11.4M Buy
162,900
+1,400
+0.9% +$99.2K 0.08% 313
2023
Q2 		$11.2M Buy
161,500
+28,700
+22% +$2.04M 0.07% 384
2023
Q1 		$9.87M Buy
132,800
+82,400
+163% +$6.91M 0.06% 463
2022
Q4 		$4.7M Buy
50,400
+16,700
+50% +$1.61M 0.03% 1072
2022
Q3 		$3.21M Buy
33,700
+28,000
+491% +$2.77M 0.02% 1514
2022
Q2 		$528K Buy
+5,700
New +$556K ﹤0.01% 3015

Other funds holding CVS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Cubist Systematic Strategies's CVS Position: Q1 2025 in Review

Cubist Systematic Strategies sold out of CVS Health (CVS) in Q1 2025, closing a stake of 459,045 shares — an estimated $27.5M sold.

Cubist Systematic Strategies first reported a position in CVS in Q2 2014 and held it in 39 quarters. The position peaked at $73.7M in Q1 2023. 1,756 funds tracked by Wall St. Rank hold CVS as of Q1 2025.

  • Cubist Systematic Strategies reported no remaining CVS Health position as of Q1 2025 after selling out during the quarter.
  • Cubist Systematic Strategies sold 459,045 CVS Health shares in Q1 2025, an estimated $27.5M.
  • Cubist Systematic Strategies first reported a position in CVS Health in Q2 2014 and held it in 39 quarters.
  • Cubist Systematic Strategies's CVS Health position peaked at $73.7M in Q1 2023.
  • 1,756 funds tracked by Wall St. Rank held CVS Health as of Q1 2025.

Based on Cubist Systematic Strategies's 13F filing for Q1 2025, filed 15 May 2025.